These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Recent advances in the management of women with ovarian cancer. Eltabbakh GH Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412 [TBL] [Abstract][Full Text] [Related]
26. [Chemoresistance in ovarian cancer. State of the art and future prospects]. Katsaros D; Fracchioli S; Arese P; Enria R; Cassinelli P; Mingrone K; Piccinno R; Rigault de la Longrais IA; Massobrio M Minerva Ginecol; 1999 Dec; 51(12):483-99. PubMed ID: 10767997 [TBL] [Abstract][Full Text] [Related]
27. New options for the treatment of advanced ovarian cancer. Dunton CJ Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739 [TBL] [Abstract][Full Text] [Related]
28. Epithelial ovarian cancer: second and third line chemotherapy (review). Latorre A; De Lena M; Catino A; Crucitta E; Sambiasi D; Guida M; Misino A; Lorusso V Int J Oncol; 2002 Jul; 21(1):179-86. PubMed ID: 12063566 [TBL] [Abstract][Full Text] [Related]
35. Epithelial ovarian cancer: Does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance? Larsen E; Blaakaer J Acta Obstet Gynecol Scand; 2009; 88(4):373-7. PubMed ID: 19253061 [TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for ovarian cancer: an evidence-based approach. Geisler JP; Manahan KJ; Wiemann MC Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]